BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11418363)

  • 1. Spanish contributions to management of acute promyelocytic leukemia.
    Haematologica; 2001 Jun; 86(6):561-2. PubMed ID: 11418363
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring of minimal residual disease in acute promyelocytic leukemia.
    Lengfelder E; Reiter A; Saussele S; Weisser A; Hehlmann R
    Ann Hematol; 2004; 83 Suppl 1():S79-80. PubMed ID: 15124684
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy of acute promyelocytic leukemia.
    Soignet S; Maslak P
    Adv Pharmacol; 2004; 51():35-58. PubMed ID: 15464904
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute promyelocytic leukemia and constitutional trisomy 21.
    Kurkjian C; Patel S; Kamble R; Dunn ST; Kern W; Kharfan-Dabaja MA
    Cancer Genet Cytogenet; 2006 Mar; 165(2):176-9. PubMed ID: 16527614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary near-tetraploidy with double der(15)t(15;17) in acute promyelocytic leukemia in relapse.
    Morita Y; Takahashi A; Yamamoto K; Miki T; Murakami N; Miura O
    Cancer Genet Cytogenet; 2004 Mar; 149(2):131-6. PubMed ID: 15036889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
    Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
    Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute promyelocytic leukemia: recent advances in diagnosis and management.
    Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
    Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy-related acute myeloid leukemia after successful therapy for acute promyelocytic leukemia with t(15;17): A case report and literature review.
    Bao L; Lu X; Lai Y; Zhang X; Zhu H; Liu Y; Qin Y; Huang XJ
    Leuk Res; 2009 Jul; 33(7):e64-8. PubMed ID: 19297021
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of PML-RARA rearrangement by RT-PCR and sequencing in an acute promyelocytic leukemia without t(15;17) on G-banding and FISH.
    Han JY; Kim KE; Kim KH; Park JI; Kim JS
    Leuk Res; 2007 Feb; 31(2):239-43. PubMed ID: 16797070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A large exon 6 break in V-form acute promyelocytic leukemia: relevance to clinical management.
    Bussaglia E; Guardia R; Nomdedéu JF
    Leukemia; 2007 Nov; 21(11):2356-7. PubMed ID: 17568815
    [No Abstract]   [Full Text] [Related]  

  • 11. Derivative (7)t(7;8): The sole karyotype abnormality in acute promyelocytic leukemia with PML/RARA rearrangement identified by RT-PCR and sequence analysis.
    Wang Y; Fang M; Jing Y; Li J; Jiang F; Wang Y
    Leuk Res; 2009 Jul; 33(7):e55-8. PubMed ID: 19162322
    [No Abstract]   [Full Text] [Related]  

  • 12. Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.
    Zhu HH; Liu YR; Qin YZ; Jiang B; Shan FX; Wu SL; Yang PD; Zhao J; Lu DP
    Chin Med J (Engl); 2007 Oct; 120(20):1803-8. PubMed ID: 18028775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group).
    Cassinat B; de Botton S; Kelaidi C; Ades L; Zassadowski F; Guillemot I; Schlageter MH; Raffoux E; Harousseau JL; Legrand O; Escoffre-Barbe M; Reman O; Gardembas M; Himberlin C; Cahn JY; Guyotat D; Bouscary D; Parry A; Rousselot P; Baruchel A; Dombret H; Chevret S; Fenaux P; Chomienne C
    Leuk Res; 2009 Sep; 33(9):1178-82. PubMed ID: 19167754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of minimal residual disease in patients with t(15;17).
    Grimwade D
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):137-58. PubMed ID: 11987921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The apparent excess of acute promyelocytic leukemia in infant acute leukemias in Brazil.
    Mendes WL; Coser VM; Ramos G; Pereira W; Lopes LF; de Oliveira MS
    Haematologica; 2004 Nov; 89(11):ELT16. PubMed ID: 15533849
    [No Abstract]   [Full Text] [Related]  

  • 16. Real-time quantification of the multidrug resistance-1 gene expression in relapsed acute promyelocytic leukemia treated with arsenic trioxide.
    Au WY; Chim CS; Wai Lie AK; Pang A; Kwong YL
    Haematologica; 2002 Oct; 87(10):1109-11. PubMed ID: 12368167
    [No Abstract]   [Full Text] [Related]  

  • 17. A new complex translocation t(5;17;15)(q11;q21;q22) in acute promyelocytic leukemia.
    Abe S; Ishikawa I; Harigae H; Sugawara T
    Cancer Genet Cytogenet; 2008 Jul; 184(1):44-7. PubMed ID: 18558288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new cytogenetic abnormality, t(2;7)(q33;q36), in acute promyelocytic leukemia.
    Owatari S; Uozumi K; Haraguchi K; Ohno N; Tokunaga M; Tokunaga M; Suzuki S; Hanada S; Arima N
    Cancer Genet Cytogenet; 2007 Feb; 173(1):71-4. PubMed ID: 17284374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia.
    Daly AS; Kamel-Reid S; Lipton JH; Messner HA; Kiss TL; Chun K; Busque L; Chang H
    Leuk Res; 2004 Oct; 28(10):1107-11. PubMed ID: 15289025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
    Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
    Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.